Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$963M |
| 3 |
Wells Fargo
WFC
|
+$647M |
| 4 |
ConocoPhillips
COP
|
+$632M |
| 5 |
UnitedHealth
UNH
|
+$490M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$963M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$907M |
| 3 |
KKR & Co
KKR
|
+$906M |
| 4 |
CRH
CRH
|
+$670M |
| 5 |
Meta Platforms (Facebook)
META
|
+$593M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.49% |
| 2 | Technology | 10.44% |
| 3 | Healthcare | 8.01% |
| 4 | Financials | 6.79% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
PUT
Albemarle
ALB
$16.2B
| $8.12M | ﹤0.01% |
85,000
+18,200
| +27% | +$2.16M |
|
|
ETNB
2177
DELISTED
89bio
ETNB
| $8.09M | ﹤0.01% |
1,010,352
-76,845
| -7% | -$686K |
|
2178
CALL
Vistra
VST
$46B
| $8.09M | ﹤0.01% |
+94,100
| New | +$7.87M |
|
2179
Huntington Bancshares
HBAN
$34.2B
| $8.09M | ﹤0.01% |
613,625
-11,080,633
| -95% | -$149M |
|
|
TEM
2180
Tempus AI
TEM
$11.6B
| $8.07M | ﹤0.01% |
+230,487
| New | +$7.07M |
|
2181
CALL
Norwegian Cruise Line
NCLH
$7.65B
| $8.06M | ﹤0.01% |
428,700
+73,500
| +21% | +$1.29M |
|
|
NVRO
2182
DELISTED
NEVRO CORP.
NVRO
| $8.05M | ﹤0.01% |
956,542
+168,573
| +21% | +$1.8M |
|
2183
PUT
Teradyne
TER
$55.5B
| $8.05M | ﹤0.01% |
54,300
-8,000
| -13% | -$1.02M |
|
2184
PUT
Academy Sports + Outdoors
ASO
$2.7B
| $8.05M | ﹤0.01% |
151,200
+121,600
| +411% | +$6.91M |
|
2185
CALL
Centene
CNC
$32B
| $8.04M | ﹤0.01% |
121,200
-309,700
| -72% | -$22.5M |
|
2186
State Street Communication Services Select Sector SPDR ETF
XLC
$22.8B
| $8.02M | ﹤0.01% |
93,589
+37,550
| +67% | +$3.09M |
|
2187
Dollar General
DG
$27.1B
| $8M | ﹤0.01% |
60,530
-83,237
| -58% | -$11.6M |
|
2188
Atmus Filtration Technologies
ATMU
$3.89B
| $8M | ﹤0.01% |
278,004
-62,264
| -18% | -$1.89M |
|
2189
Sony
SONY
$145B
| $8M | ﹤0.01% |
470,920
+358,885
| +320% | +$5.93M |
|
2190
Freshworks
FRSH
$3.62B
| $8M | ﹤0.01% |
630,305
-1,942,330
| -75% | -$29.1M |
|
2191
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.43B
| $7.99M | ﹤0.01% |
38,999
-67,592
| -63% | -$13.6M |
|
2192
ALX Oncology
ALXO
$277M
| $7.99M | ﹤0.01% |
1,325,196
+1,265,006
| +2,102% | +$15.6M |
|
|
CGAU
2193
Centerra Gold
CGAU
$4.59B
| $7.99M | ﹤0.01% |
1,188,608
-92,579
| -7% | -$607K |
|
2194
Viatris
VTRS
$18.8B
| $7.99M | ﹤0.01% |
751,200
+348,250
| +86% | +$3.85M |
|
|
INZY
2195
DELISTED
Inozyme Pharma
INZY
| $7.97M | ﹤0.01% |
1,787,947
+1,084,341
| +154% | +$5.26M |
|
2196
Vishay Intertechnology
VSH
$4.69B
| $7.96M | ﹤0.01% |
357,052
-744,037
| -68% | -$16.8M |
|
2197
PUT
United States Oil Fund
USO
$2.03B
| $7.96M | ﹤0.01% |
100,000
-270,000
| -73% | -$21M |
|
2198
Indivior Pharmaceuticals
INDV
$4.12B
| $7.95M | ﹤0.01% |
493,313
+160,282
| +48% | +$2.89M |
|
|
APLS
2199
DELISTED
Apellis Pharmaceuticals
APLS
| $7.9M | ﹤0.01% |
205,911
-579,485
| -74% | -$26.2M |
|
2200
EXL Service
EXLS
$5.82B
| $7.9M | ﹤0.01% |
251,824
-249,569
| -50% | -$7.49M |
|
Similar funds
Israel Englander's Q2 2024 Portfolio in Review
As of Q2 2024, Israel Englander held 6,803 positions worth $216B, down 7.8% from $234B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Israel Englander's Q2 2024 filing shows 661 new, 2,109 increased, 2,549 reduced and 995 closed positions. Its largest new stake was QXO Inc: 2,219,158 shares worth $20.6M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $963M.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2024 buy was QXO Inc: 2,219,158 shares worth $20.6M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $1.12B increase.
- Israel Englander's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $963M.
- Israel Englander fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $907M.
- Israel Englander's ten largest holdings make up 16% of its $216B portfolio in Q2 2024.
- Israel Englander opened 661 new positions and closed 995 in Q2 2024.
- Israel Englander's portfolio value fell 7.8% quarter-over-quarter to $216B.
Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.